CANCER CARE AND HAEMATOLOGY FUND

Registered charity 1001358 · accounts filings on the Charity Commission register · also known as CANCER CARE AND CHEMOTHERAPY UNIT

Latest income
£108k
Latest spending
£81k
Registered
1990
Accounts read
FY2023

Financial health, per its FY2023 accounts

The accounts state that total funds increased to £1,218,821 by the end of the year, driven by a net income of £132,621 against charitable expenditure of £89,595. The charity reports a steady return to normal fundraising levels and increased donations following the lifting of pandemic restrictions. Unrestricted reserves are held at £1,147,560, with no stated reserves policy target provided in the filing.

What the accounts disclose

Accounts independently examined (not a full audit).

Public fundraising profile: JustGiving — Cancer Care And Haematology Fund (matched by registered charity number).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Bedford · Buckinghamshire · Central Bedfordshire · Hertfordshire · Oxfordshire

Income and spending

Financial year endIncomeSpending
31/03/2025£108k£81k
31/03/2024£101k£254k
31/03/2023£171k£38k
31/03/2022£27k£90k
31/03/2021£44k£51k

Common questions

Is CANCER CARE AND HAEMATOLOGY FUND financially healthy?

The accounts state that total funds increased to £1,218,821 by the end of the year, driven by a net income of £132,621 against charitable expenditure of £89,595. The charity reports a steady return to normal fundraising levels and increased donations following the lifting of pandemic restrictions. Unrestricted reserves are held at £1,147,560, with no stated reserves policy target provided in the filing. Its FY2023 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE CANCER TREATMENT AND RESEARCH TRUST CIO.